[go: up one dir, main page]

DE69626691D1 - Komponente b als wundheilendes mittel - Google Patents

Komponente b als wundheilendes mittel

Info

Publication number
DE69626691D1
DE69626691D1 DE69626691T DE69626691T DE69626691D1 DE 69626691 D1 DE69626691 D1 DE 69626691D1 DE 69626691 T DE69626691 T DE 69626691T DE 69626691 T DE69626691 T DE 69626691T DE 69626691 D1 DE69626691 D1 DE 69626691D1
Authority
DE
Germany
Prior art keywords
component
pct
healing agent
wounds healing
wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626691T
Other languages
English (en)
Other versions
DE69626691T2 (de
Inventor
Francesco Borrelli
Silvia Donini
Fabrizio Martelli
Renato Mastrangeli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Publication of DE69626691D1 publication Critical patent/DE69626691D1/de
Application granted granted Critical
Publication of DE69626691T2 publication Critical patent/DE69626691T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Glass Compositions (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69626691T 1996-04-24 1996-04-24 Komponente b als wundheilendes mittel Expired - Fee Related DE69626691T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002251356A CA2251356A1 (en) 1996-04-24 1996-04-24 Component b as cicatrizant
PCT/EP1996/001702 WO1997039765A1 (en) 1996-04-24 1996-04-24 Component b as cicatrizant

Publications (2)

Publication Number Publication Date
DE69626691D1 true DE69626691D1 (de) 2003-04-17
DE69626691T2 DE69626691T2 (de) 2003-08-14

Family

ID=25680594

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626691T Expired - Fee Related DE69626691T2 (de) 1996-04-24 1996-04-24 Komponente b als wundheilendes mittel

Country Status (14)

Country Link
US (1) US5998364A (de)
EP (1) EP0895478B1 (de)
JP (1) JP3882943B2 (de)
AT (1) ATE234110T1 (de)
AU (1) AU727618B2 (de)
CA (1) CA2251356A1 (de)
DE (1) DE69626691T2 (de)
DK (1) DK0895478T3 (de)
EA (1) EA001077B1 (de)
ES (1) ES2188754T3 (de)
IL (1) IL120696A (de)
NO (1) NO320611B1 (de)
WO (1) WO1997039765A1 (de)
ZA (1) ZA973442B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2336773C (en) * 1998-07-09 2009-12-15 Applied Research Systems Ars Holding N.V. Component b as angiogenic agent in combination with human growth factors
WO2004091646A2 (en) * 2003-04-16 2004-10-28 Applied Research Systems Ars Holding, N.V. Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK339781A (da) * 1980-08-05 1982-02-06 Searle & Co Syntetisk gen
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale

Also Published As

Publication number Publication date
US5998364A (en) 1999-12-07
JP3882943B2 (ja) 2007-02-21
IL120696A (en) 2001-10-31
IL120696A0 (en) 1997-08-14
EP0895478A1 (de) 1999-02-10
WO1997039765A1 (en) 1997-10-30
ZA973442B (en) 1998-02-23
NO320611B1 (no) 2005-12-27
NO984965L (no) 1998-12-01
EA001077B1 (ru) 2000-10-30
NO984965D0 (no) 1998-10-23
EA199800953A1 (ru) 1999-04-29
AU5760596A (en) 1997-11-12
JP2000510436A (ja) 2000-08-15
EP0895478B1 (de) 2003-03-12
DK0895478T3 (da) 2003-06-23
ES2188754T3 (es) 2003-07-01
ATE234110T1 (de) 2003-03-15
AU727618B2 (en) 2000-12-14
DE69626691T2 (de) 2003-08-14
CA2251356A1 (en) 1997-10-30

Similar Documents

Publication Publication Date Title
DE69932183D1 (de) ANWENDUNG VON ZIELGERICHTETEM RADIUM 223 FüR PALLIATIVE UND THERAPEUTISCHE BEHANDLUNG VON KNOCHENKREBS
ATE254905T1 (de) Verwendung mindestens eines hydroxystilben in einer straffenden zusammensetzung
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
SE9702860D0 (sv) New use
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
ATE285219T1 (de) Rekombinante haarbehandlungsmittel
MY164077A (en) Compositions and uses of et743 for treating cancer
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
PT1390007E (pt) Composição cosmética à base de sucralfato e de sulfatos de cobre e de zinco
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
DE69626691D1 (de) Komponente b als wundheilendes mittel
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
GB9516073D0 (en) Pharmaceutical composition
AU5986498A (en) Use of aminothiazoles for treating wounds and skin
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
GR3031890T3 (en) Use of topically applied factor xiii for inhibiting hemorrhage.
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
MD980129A (en) Antiherpetic remedy
SE9403861D0 (sv) Novel medicinal use
GB9723824D0 (en) Cytostatic agents
UA42335A (uk) Спосіб лікування гнійних ран
UA9703A (uk) Антипротеіназний засіб
GB9812278D0 (en) Use of a wound dressing in the treatment of acute wounds
UA32315A (uk) Спосіб накладання шкірного шва

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH

8339 Ceased/non-payment of the annual fee